Work

Survival outcomes of cabozantinib treatment with and without immune checkpoint inhibition in patients with heavily pretreated advanced sarcoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11551

Authors: Lauren Li, Andreana Yang Leow, Maggie Yuxi Zhou, Nam Bui, Allison Pribnow, Kristen Nooshin Ganjoo, Minggui Pan

Institutions: Stanford Health Care, Stanford University, Stanford Medicine, Stanford Cancer Institute

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162537778

Cites:

Cited by:

Related to: